Chronic periprosthetic joint infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria included patients who underwent debridement for PJI, implantation of temporary antibiotic spacers, and removal of spacers and reimplantation arthroplasty.
Exclusion criteria
Exclusion criteria: Exclusion criteria included: (1) PJI patients with inflammatory joint diseases such as rheumatoid arthritis, ankylosing spondylitis, and systemic lupus erythematosus; (2) patients had venous thromboembolism (VTE), including pulmonary embolism (PE) or deep venous thrombosis (DVT), 6 weeks before reimplantation; (3) patients with other hematological or cardiovascular diseases that require antithrombotic drugs ; (4) patients who had previously undergone two-stage revision surgery; (5) patients with multiple joint infections simultaneously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| C-reactive protein;Erythrocyte sedimentation rate, ESR;Interleukin-6;Fibrinogen;Monocyte to lymphocyte ratio (MLR);Neutrophil-to-lymphocyte ratio (NLR);Platelet to lymphocyte ratio (PLR);CRP/albumin ratio (CAR);CRP to lymphocyte ratio (CLR);CRP to fibrinogen ratio (CFR) ; | — |
Countries
China
Contacts
West China Hospital, Sichuan University